What’s Vulnerable › Vulnerabilities

CVE-2018-14787

• Severity: high (CVSS 7.8 v3.1)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 0.4% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2018-08-22 · updated 2026-06-17
• Weakness: CWE-269

Description

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.

Affected products

• Philips Intellispace Cardiovascular: through 3.1
• Philips Xcelera: through 4.1

References

• https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01
• https://www.usa.philips.com/healthcare/about/customer-support/product-security
• https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01
• https://www.usa.philips.com/healthcare/about/customer-support/product-security

Get alerted when CVE-2018-14787 or the next vulnerability affects your stack